Literature DB >> 2998527

Cl-/Ca2+-dependent L-glutamate binding sites do not correspond to 2-amino-4-phosphonobutanoate-sensitive excitatory amino acid receptors.

G E Fagg, T H Lanthorn.   

Abstract

A series of phosphono and phosphino analogues of glutamate were used to compare the pharmacological properties of (a) Cl-/Ca2+-dependent, 2-amino-4-phosphonobutanoate (AP4)-sensitive L-[3H]-glutamate binding sites in rat brain synaptic plasma membranes (SPMs) and (b) AP4-sensitive excitatory synaptic responses by use of electrophysiological techniques. In the presence of Cl- and Ca2+, L-[3H]-glutamate bound to SPMs with Kd 804 nM and Bmax 53 pmol mg-1 protein. The AP4-sensitive (Ki 7.3 microM) population of binding sites represented 61% of L-glutamate specifically bound. omega-Substituted analogues of AP4 were potent inhibitors of L-[3H]-glutamate binding (Ki values 2.4-38 microM), whereas N-substituted compounds or propionic acid derivatives were inactive. Experiments with AP4 alone and in combination with other analogues demonstrated that the primary target of all substances was the AP4-sensitive population of L-glutamate binding sites. In the hippocampal slice in vitro, AP4 antagonized lateral perforant path-evoked field potentials with an IC50 of 2.7 microM. In contrast to their actions at AP4-sensitive L-glutamate binding sites, all other compounds (except for the omega-carboxymethylphosphino analogue, IC50 19 microM) were weak or inactive as antagonists of this synaptic response (IC50 values greater than 100 microM). Inactive compounds which exhibited activity in the binding assay did not reverse the synaptic depressant effects of AP4, indicating that they were neither agonists nor antagonists at AP4-sensitive synapses. 4 The lack of correspondence between (a) the Cl- /Ca2 -dependent, AP4-sensitive population of L- [3H]-glutamate binding sites and (b) AP4-sensitive synaptic responses indicates that these binding sites are not the receptors through which AP4 exerts its neuropharmacological effects. The possibility that Cl- /Ca2+-dependent 'binding sites' represent transport into resealed SPM vesicles is discussed. 5 Electrophysiological data demonstrate that AP4-sensitive synaptic receptors display a high degree of ligand selectivity. High antagonist potency is shown only by glutamate analogues with unmodified alpha-amino and alpha-carboxyl groups, and with a bifunctional (dianionic) omega-terminal.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998527      PMCID: PMC1916736          DOI: 10.1111/j.1476-5381.1985.tb08954.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Synaptosomal transport: a chloride dependence for choline, GABA, glycine and several other compounds.

Authors:  M J Kuhar; M A Zarbin
Journal:  J Neurochem       Date:  1978-07       Impact factor: 5.372

3.  Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation.

Authors:  D H Jones; A I Matus
Journal:  Biochim Biophys Acta       Date:  1974-08-09

Review 4.  Excitatory amino acid transmitters.

Authors:  J C Watkins; R H Evans
Journal:  Annu Rev Pharmacol Toxicol       Date:  1981       Impact factor: 13.820

5.  High affinity l-[3h]glutamate binding to postsynaptic receptor sites on rat cerebellar membranes.

Authors:  A C Foster; P J Roberts
Journal:  J Neurochem       Date:  1978-12       Impact factor: 5.372

6.  The effects of a series of omega-phosphonic alpha-carboxylic amino acids on electrically evoked and excitant amino acid-induced responses in isolated spinal cord preparations.

Authors:  R H Evans; A A Francis; A W Jones; D A Smith; J C Watkins
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

7.  2-amino-4-phosphonobutyric acid: a new pharmacological tool for retina research.

Authors:  M M Slaughter; R F Miller
Journal:  Science       Date:  1981-01-09       Impact factor: 47.728

8.  L-Aspartate transport into plasma membrane vesicles derived from rat brain synaptosomes.

Authors:  J G Marvizón; F Mayor; M C Aragón; C Giménez; F Valdivieso
Journal:  J Neurochem       Date:  1981-12       Impact factor: 5.372

9.  Baclofen selectively inhibits excitatory synaptic transmission in the hippocampus.

Authors:  T H Lanthorn; C W Cotman
Journal:  Brain Res       Date:  1981-11-23       Impact factor: 3.252

10.  Micromolar L-2-amino-4-phosphonobutyric acid selectively inhibits perforant path synapses from lateral entorhinal cortex.

Authors:  J F Koerner; C W Cotman
Journal:  Brain Res       Date:  1981-07-06       Impact factor: 3.252

View more
  6 in total

1.  [3H]-L-2-amino-4-phosphonobutyrate labels a metabotropic glutamate receptor, mGluR4a.

Authors:  L Eriksen; C Thomsen
Journal:  Br J Pharmacol       Date:  1995-12       Impact factor: 8.739

2.  Identification and properties of N-methyl-D-aspartate receptors in rat brain synaptic plasma membranes.

Authors:  D T Monaghan; C W Cotman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

3.  Characterization of ionotropic glutamate receptors in human lymphocytes.

Authors:  G Lombardi; C Dianzani; G Miglio; P L Canonico; R Fantozzi
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

4.  Pharmacological characterization of glutamate binding sites in cultured cerebellar granule cells and cortical astrocytes.

Authors:  I Holopainen; P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1994-02       Impact factor: 3.996

5.  Removal of extracellular chloride suppresses transmitter release from photoreceptor terminals in the mudpuppy retina.

Authors:  W B Thoreson; R F Miller
Journal:  J Gen Physiol       Date:  1996-05       Impact factor: 4.086

6.  Actions of (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) in retinal ON bipolar cells indicate that it is an agonist at L-AP4 receptors.

Authors:  W B Thoreson; R F Miller
Journal:  J Gen Physiol       Date:  1994-06       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.